Linked Life Data

16396712

Source:http://linkedlifedata.com/resource/pubmed/id/16396712

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-1-10
pubmed:abstractText
Anti-TNFalpha strategies can result in significant clinical benefits in rheumatoid arthritis (RA), but with an increased rate of opportunistic infections. Visceral leishmaniasis (VL) is a severe disease that can develop in immunocompromised hosts, principally in HIV patients. VL in RA patients treated with TNFalpha antagonists is an extremely rare event, and only one case has been described. Here we report a case of VL, occurring after 9 infusions of infliximab in association with azathioprine, in a patient who developed blood cytopenia, fluctuant fever, and splenomegaly.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0392-856X
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
891-2
pubmed:meshHeading
pubmed:articleTitle
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab.
pubmed:affiliation
Department of Immuno-Rheumatology, CHU Lapeyronie, 371 av Doyen Gaston Giraud, 34090 Montpellier, France. s-fabre@chu-montpellier.fr
pubmed:publicationType
Journal Article, Case Reports